Can sugar in urine predict kidney drug success?

NCT ID NCT07084038

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 300 adults with chronic kidney disease who are already taking SGLT2 inhibitors. Researchers want to see if the amount of sugar in their urine is linked to changes in protein levels, a key marker of kidney damage. The goal is to find a simple way to tell if the drug is working well and possibly adjust doses for better results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SGLT2 inhibitor

What this could lead to

If successful, this could help doctors personalize SGLT2 inhibitor doses for better kidney protection in chronic kidney disease.

What could go wrong

This is an observational analysis, not a treatment trial. It may not lead to direct changes in care, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chinese PLA General Hospital,

    Beijing, Beijing Municipality, 100853, China